These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045 [TBL] [Abstract][Full Text] [Related]
3. Regional cerebral glucose transport and utilization in Alzheimer's disease. Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318 [TBL] [Abstract][Full Text] [Related]
4. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929 [TBL] [Abstract][Full Text] [Related]
5. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software]. Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271 [TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study. Meguro K; Yamaguchi S; Itoh M; Fujiwara T; Yamadori A Neurology; 1997 Oct; 49(4):941-5. PubMed ID: 9339671 [TBL] [Abstract][Full Text] [Related]
7. Cerebral glucose metabolism in patients with frontotemporal dementia. Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Friedland RP; Budinger TF; Koss E; Ober BA Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424 [TBL] [Abstract][Full Text] [Related]
9. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment]. Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368 [TBL] [Abstract][Full Text] [Related]
10. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease. Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180 [TBL] [Abstract][Full Text] [Related]
11. Cortical abnormalities in Alzheimer's disease. Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378 [TBL] [Abstract][Full Text] [Related]
12. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism]. Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949 [TBL] [Abstract][Full Text] [Related]
14. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity]. Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383 [TBL] [Abstract][Full Text] [Related]
15. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. Ishii K; Sasaki M; Kitagaki H; Yamaji S; Sakamoto S; Matsuda K; Mori E J Nucl Med; 1997 Jun; 38(6):925-8. PubMed ID: 9189143 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease. McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063 [TBL] [Abstract][Full Text] [Related]